Expecting mothers facing pain or fever during pregnancy face a complex clinical dilemma: these conditions require effective treatment, yet safety concerns about medication use create uncertainty. A new PLOS Medicine perspective offers crucial insights for navigating this challenge.
First, pain and fever during pregnancy cannot be ignored and demand appropriate medical management. Second, the relationship between first-trimester NSAID use and birth defects is more complicated than blanket warnings suggest, requiring individualized risk assessment rather than categorical prohibitions. Third, one-size-fits-all recommendations may not serve patients well.
The research underscores that clinical decision-making should be tailored to each patient’s specific situation, weighing the benefits of pain management against potential risks. Rather than avoiding NSAIDs categorically, healthcare providers should engage in shared decision-making conversations with pregnant women, discussing individual risk factors and available alternatives.
Read the full article on GMJ Newsroom.
Was this article helpful?
